EchoSolv AS vs ZEUS System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Echo IQ
VS
by iRhythm Technologies

AI Verdict

EchoSolv AS provides AI-powered clinical decision support for identifying patients at risk of severe aortic stenosis by analyzing echocardiogram measurements. The ZEUS System, conversely, uses AI to analyze ECG data from wearable biosensors for long-term continuous cardiac monitoring, focusing on the detection and characterization of arrhythmias. While both are FDA-cleared cardiology AI tools, they address different cardiac conditions and utilize distinct data inputs and monitoring approaches.

Choose EchoSolv AS if…

Choose EchoSolv AS if your primary goal is to efficiently and accurately identify patients at high risk for severe aortic stenosis using existing echocardiogram data. This AI-powered platform provides rapid, measurement-based clinical decision support, acting as a second reader to help prioritize studies for closer review within your current cardiology workflow.

View EchoSolv AS →

Choose ZEUS System if…

Choose the ZEUS System if you need long-term, continuous cardiac monitoring to detect and characterize arrhythmias, such as Atrial Fibrillation. This AI-powered software analyzes ECG data from wearable biosensors for up to 14 days, providing comprehensive insights for both symptomatic and asymptomatic cardiac events.

View ZEUS System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature EchoSolv AS ZEUS System
Pricing Unknown Not disclosed
Deployment Cloud-based Cloud-based (AWS EC2 platform), no on-premise hardware.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoSolv AS

EchoSolv AS is designed to integrate seamlessly into existing echocardiogram workflows, explicitly stating no EMR integration is required and offering PACS integration. Its ultra-fast risk detection (under 3 seconds) further enhances efficiency. While the ZEUS System offers EHR integration, its reliance on wearable devices introduces a different patient and clinical workflow.

Clinical Value

EchoSolv AS

Both tools are FDA-cleared and provide significant clinical value in cardiology. EchoSolv AS offers highly accurate and efficient identification of severe aortic stenosis from existing echocardiogram data, addressing a critical need for timely diagnosis of a life-threatening condition. The ZEUS System provides valuable long-term arrhythmia detection, but EchoSolv AS's focused impact on a severe structural heart disease from routine imaging gives it a slight edge in direct clinical impact for its specific niche.

Pricing & Value

ZEUS System

The ZEUS System, particularly its Zio Patch component, has more publicly available information regarding reimbursement rates and even a direct self-pay option, offering a clearer, albeit complex, picture of potential costs. EchoSolv AS's pricing is described as a subscription-based, fee-per-use model with a revenue split, but the overall cost structure for healthcare providers or patients is less transparent in the available information.

Enterprise Readiness

ZEUS System

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, BAA, and cloud deployment. However, the ZEUS System's explicit mention of HL7-based EHR integration aligns with standard enterprise data exchange requirements, which is a critical factor for comprehensive integration within large healthcare systems. EchoSolv AS's 'no EMR integration required' might simplify initial deployment but HL7 offers deeper system integration.

Innovation

ZEUS System

The ZEUS System demonstrates greater innovation by combining long-term wearable biosensors with AI for continuous cardiac monitoring, enabling the detection of both symptomatic and asymptomatic arrhythmias over extended periods. This represents a more significant shift in data collection and diagnostic methodology compared to EchoSolv AS's refinement of existing echocardiogram analysis.

Support & Docs

ZEUS System

The ZEUS System offers more comprehensive support and documentation, including a dedicated team of patient advocates, a professional web portal (ZioSuite) for workflow management, and explicit 'Instructions for Use' for its software. EchoSolv AS's mentioned documentation appears to be primarily for streamlining reimbursement processes rather than direct user or technical support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature EchoSolv AS ZEUS System
Tool Name EchoSolv AS ZEUS System
Company Echo IQ iRhythm Technologies
Primary Clinical Focus Identify patients at risk for severe aortic stenosis Detection and characterization of arrhythmias like Atrial Fibrillation
Input Data Analyzed Echocardiogram measurements ECG data from wearable biosensors
Integration Capabilities Integrates with PACS (no EMR integration required) HL7-based EHR integration, integration with Zio Watch and Zio monitors
Analysis Speed / Duration Ultra-fast risk detection (under 3 seconds) Continuous ECG monitoring (up to 14 days)

Videos

Demos, reviews, and walkthroughs featuring EchoSolv AS and ZEUS System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EchoSolv AS is designed to identify patients at risk for severe aortic stenosis by analyzing echocardiogram measurements. The ZEUS System, on the other hand, focuses on detecting and characterizing arrhythmias, such as Atrial Fibrillation, through continuous ECG monitoring from wearable biosensors.
EchoSolv AS analyzes numerical measurements obtained from echocardiograms, rather than images, to provide its risk assessment. The ZEUS System processes ECG data collected from wearable biosensors, specifically integrating with Zio Watch and Zio monitors.
EchoSolv AS is designed to fit into existing workflows and integrates with PACS, without requiring EMR integration. The ZEUS System offers HL7-based EHR integration to streamline data flow into a physician's electronic health records.
EchoSolv AS provides AI-powered clinical decision support for severe aortic stenosis probability, including consistent severe AS probability and guideline checks, and offers second reader support. The ZEUS System delivers AI-powered arrhythmia detection, continuous ECG monitoring for up to 14 days, and generates preliminary reports for physicians.
EchoSolv AS offers ultra-fast risk detection, providing results in under 3 seconds. In contrast, the ZEUS System is designed for long-term continuous cardiac monitoring, capable of analyzing ECG data for up to 14 days.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.